Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
35,033
archived clinical trials in
Lung Cancer

Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients With Extensive Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
St Mary's Medical Center
mi
from
Huntington, WV
Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients With Extensive Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
St Mary's Medical Center
mi
from
Huntington, WV
Click here to add this to my saved trials
Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients With Extensive Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Ministry Medical Group - Northern Region
mi
from
Rhinelander, WI
Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients With Extensive Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Ministry Medical Group - Northern Region
mi
from
Rhinelander, WI
Click here to add this to my saved trials
Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients With Extensive Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
McGill University
mi
from
Montreal,
Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients With Extensive Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
McGill University
mi
from
Montreal,
Click here to add this to my saved trials
The First Therapeutic Intervention in Malignant Pleural Effusion Trial
TIME1: A 2 X 2 Factorial Trial to Assess Whether Non-steroidal Anti-inflammatory Analgesics and Small-bore Chest Tubes Are Less Painful Than Opiate Analgesics and Large-bore Chest Tubes in Pleurodesis for Malignant Pleural Effusion.
Status: Enrolling
Updated:  7/16/2015
UC Davis Medical Center
mi
from
Sacramento, CA
The First Therapeutic Intervention in Malignant Pleural Effusion Trial
TIME1: A 2 X 2 Factorial Trial to Assess Whether Non-steroidal Anti-inflammatory Analgesics and Small-bore Chest Tubes Are Less Painful Than Opiate Analgesics and Large-bore Chest Tubes in Pleurodesis for Malignant Pleural Effusion.
Status: Enrolling
Updated: 7/16/2015
UC Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer
Pemetrexed and LBH589 in Previously-Treated Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/20/2015
Hillman Cancer Center
mi
from
Pittsburgh, PA
Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer
Pemetrexed and LBH589 in Previously-Treated Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/20/2015
Hillman Cancer Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Improving Management of Breathlessness in Patients With Lung Cancer
Improving Management of Breathlessness in Patients With Lung Cancer
Status: Enrolling
Updated:  7/20/2015
Massachusetts General Hospital
mi
from
Boston, MA
Improving Management of Breathlessness in Patients With Lung Cancer
Improving Management of Breathlessness in Patients With Lung Cancer
Status: Enrolling
Updated: 7/20/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Hypofractionated Radiotherapy for Lung Cancer
The Use of Helical Tomotherapy to Achieve Dose-per-fraction Escalation in Lung Cancer
Status: Enrolling
Updated:  7/22/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Hypofractionated Radiotherapy for Lung Cancer
The Use of Helical Tomotherapy to Achieve Dose-per-fraction Escalation in Lung Cancer
Status: Enrolling
Updated: 7/22/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated:  7/22/2015
Illinois CancerCare-Peoria
mi
from
Peoria, IL
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated: 7/22/2015
Illinois CancerCare-Peoria
mi
from
Peoria, IL
Click here to add this to my saved trials
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated:  7/22/2015
Southern Illinois University School of Medicine - Obstetrics and Oncology
mi
from
Springfield, IL
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated: 7/22/2015
Southern Illinois University School of Medicine - Obstetrics and Oncology
mi
from
Springfield, IL
Click here to add this to my saved trials
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated:  7/22/2015
Saint John's Mercy Medical Center
mi
from
Saint Louis, MO
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated: 7/22/2015
Saint John's Mercy Medical Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated:  7/22/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated: 7/22/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated:  7/22/2015
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated: 7/22/2015
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated:  7/22/2015
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated: 7/22/2015
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated:  7/22/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated: 7/22/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated:  7/22/2015
City of Hope Medical Center
mi
from
Duarte, CA
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated: 7/22/2015
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated:  7/22/2015
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated: 7/22/2015
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated:  7/22/2015
University of California-Davis Comprehensive Cancer Ctr
mi
from
Sacramento, CA
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated: 7/22/2015
University of California-Davis Comprehensive Cancer Ctr
mi
from
Sacramento, CA
Click here to add this to my saved trials
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated:  7/22/2015
Moffitt Cancer Center
mi
from
Tampa, FL
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated: 7/22/2015
Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated:  7/22/2015
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated: 7/22/2015
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated:  7/22/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated: 7/22/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated:  7/22/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated: 7/22/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated:  7/22/2015
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated: 7/22/2015
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Thoracic OncoGeriatric Assessment (TOGA) Trials
Preoperative Oncogeriatric Assessment for Thoracic Malignancies
Status: Enrolling
Updated:  7/22/2015
University of Wisconsin Hospital
mi
from
Madison, WI
Thoracic OncoGeriatric Assessment (TOGA) Trials
Preoperative Oncogeriatric Assessment for Thoracic Malignancies
Status: Enrolling
Updated: 7/22/2015
University of Wisconsin Hospital
mi
from
Madison, WI
Click here to add this to my saved trials
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2015
UAB Comprehensive Cancer Center
mi
from
Birmingham, AL
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2015
UAB Comprehensive Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2015
University of California Davis Cancer Center
mi
from
Sacramento, CA
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2015
University of California Davis Cancer Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2015
Massachusetts General Hospital
mi
from
Boston, MA
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2015
Boston University Cancer Research Center
mi
from
Boston, MA
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2015
Boston University Cancer Research Center
mi
from
Boston, MA
Click here to add this to my saved trials
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2015
William Beaumont Hospital - Royal Oak Campus
mi
from
Royal Oak, MI
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2015
William Beaumont Hospital - Royal Oak Campus
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2015
Stony Brook University Cancer Center
mi
from
Stony Brook, NY
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2015
Stony Brook University Cancer Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2015
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2015
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2015
Good Samaritan Hospital Cancer Treatment Center
mi
from
Cincinnati, OH
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2015
Good Samaritan Hospital Cancer Treatment Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2015
Providence Cancer Center at Providence Portland Medical Center
mi
from
Portland, OR
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2015
Providence Cancer Center at Providence Portland Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2015
Rhode Island Hospital Comprehensive Cancer Center
mi
from
Providence, RI
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2015
Rhode Island Hospital Comprehensive Cancer Center
mi
from
Providence, RI
Click here to add this to my saved trials
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2015
H. Clay Evans Johnson Cancer Center at Memorial Hospital
mi
from
Chattanooga, TN
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2015
H. Clay Evans Johnson Cancer Center at Memorial Hospital
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2015
Medical City Dallas Hospital
mi
from
Dallas, TX
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2015
Medical City Dallas Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2015
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2015
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2015
Providence Cancer Center at Sacred Heart Medical Center
mi
from
Spokane, WA
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2015
Providence Cancer Center at Sacred Heart Medical Center
mi
from
Spokane, WA
Click here to add this to my saved trials
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2015
Providence Cancer Center at Holy Family Hospital
mi
from
Spokane, WA
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2015
Providence Cancer Center at Holy Family Hospital
mi
from
Spokane, WA
Click here to add this to my saved trials
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2015
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2015
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Assessment of Video Assisted Thoracoscopic Surgery (VATS) Versus Open Surgery for Patients Undergoing Lobectomy
A Prospective, Single Center, Observational Study Comparing the Safety and Efficacy of CVATS, HVATS and Open Surgery for Subjects Diagnosed With NSCLC Scheduled to Undergo a Lobectomy
Status: Enrolling
Updated:  7/23/2015
New York University School of Medicine
mi
from
New York, NY
Assessment of Video Assisted Thoracoscopic Surgery (VATS) Versus Open Surgery for Patients Undergoing Lobectomy
A Prospective, Single Center, Observational Study Comparing the Safety and Efficacy of CVATS, HVATS and Open Surgery for Subjects Diagnosed With NSCLC Scheduled to Undergo a Lobectomy
Status: Enrolling
Updated: 7/23/2015
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Autologous Redirected RNA Meso-CIR T Cells
Phase 1 Clinical Trial of Autologous Mesothelin Re-Directed T Cells Administered Intravenously in Patients With Progressive Malignant Pleural Mesothelioma
Status: Enrolling
Updated:  7/29/2015
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Autologous Redirected RNA Meso-CIR T Cells
Phase 1 Clinical Trial of Autologous Mesothelin Re-Directed T Cells Administered Intravenously in Patients With Progressive Malignant Pleural Mesothelioma
Status: Enrolling
Updated: 7/29/2015
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
1199.15.10001 Boehringer Ingelheim Investigational Site
mi
from
Santa Rosa, CA
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
1199.15.10001 Boehringer Ingelheim Investigational Site
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
Boehringer Ingelheim Investigational Site
mi
from
Orlando, FL
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
Boehringer Ingelheim Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
1200.45.056 Boehringer Ingelheim Investigational Site
mi
from
Port St. Lucie, FL
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
1200.45.056 Boehringer Ingelheim Investigational Site
mi
from
Port St. Lucie, FL
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
1275.1.01117 Boehringer Ingelheim Investigational Site
mi
from
St. Petersburg, FL
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
1275.1.01117 Boehringer Ingelheim Investigational Site
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
1199.14.1261 Boehringer Ingelheim Investigational Site
mi
from
Skokie, IL
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
1199.14.1261 Boehringer Ingelheim Investigational Site
mi
from
Skokie, IL
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
1199.14.1261 Boehringer Ingelheim Investigational Site
mi
from
Skokie, IL
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
1199.14.1261 Boehringer Ingelheim Investigational Site
mi
from
Skokie, IL
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
1200.167.01001 Boehringer Ingelheim Investigational Site
mi
from
Morristown, NJ
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
1200.167.01001 Boehringer Ingelheim Investigational Site
mi
from
Morristown, NJ
Click here to add this to my saved trials
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated:  7/30/2015
205.452.01189 Boehringer Ingelheim Investigational Site
mi
from
Corvallis, OR
ADAM-Afatinib Diarrhea Assessment and Management
A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)
Status: Enrolling
Updated: 7/30/2015
205.452.01189 Boehringer Ingelheim Investigational Site
mi
from
Corvallis, OR
Click here to add this to my saved trials